Drug Discovery and Development Market in Asia - Partnerships
Between MNCs and Asian Academic Institutions and Healthcare
Research Organizations are Driving R&D Innovation
NEW YORK, Nov. 19, 2012 /PRNewswire/
-- Reportlinker.com announces that a new market research
report is available in its catalogue:
Drug Discovery and Development Market in Asia - Partnerships
Between MNCs and Asian Academic Institutions and Healthcare
Research Organizations are Driving R&D Innovation
http://www.reportlinker.com/p01041697/Drug-Discovery-and-Development-Market-in-Asia---Partnerships-Between-MNCs-and-Asian-Academic-Institutions-and-Healthcare-Research-Organizations-are-Driving-RD-Innovation.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian
Academic Institutions and Healthcare Research Organizations are
Driving R&D Innovation
SummaryGBI Research, a leading business intelligence
provider, has released its latest research, "Drug Discovery and
Development Market in
Asia -
Partnerships Between MNCs and Asian Academic Institutions and
Healthcare Research Organizations are Driving R&D Innovation".
The report provides key data, information and analysis of the major
trends and issues affecting the drug discovery and development
market in seven major countries in
Asia, namely
China,
India,
Russia,
Japan,
Singapore,
Taiwan and
South
Korea. The report provides a comprehensive insight into
market segmentation, covering drug discovery and development market
sizes, the strategic context for deciding a location in
Asia to conduct clinical research,
strategies adopted by global pharmaceutical companies in
outsourcing R&D processes to Asian countries, and the
regulatory landscapes there. The report provides a detailed
analysis of the regulatory authorities, clinical trial approval
processes and recent regulatory changes in the clinical trial
environment. The report analyzes the competitive landscape of the
market, profiling key Contract Research Organizations (CRO) market
players, along with a brief description of the business, major
services and major M&A and partnership deals. The report also
provides detailed analysis of major partnership and M&A deals
that have taken place in the Asian drug discovery and development
market along with segmentation by year, deal type, geography and
phase of development.
The report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house
analysis by GBI Research's team of industry experts.
GBI Research finds that the total drug discovery and development
market size in the top seven Asian countries was estimated at
$5.3 billion in 2011 and is forecast
to reach $17.3 billion by the end of
2018. Revenue growth has been surpassed by investments in
pharmaceutical R&D that have not increased the output of new
medicines. Research-based pharmaceutical companies outsource
R&D processes to CROs which offer integrated services across
the life-sciences R&D value chain. Globalization in the
clinical trial industry has led to an increased number of trials
being conducted in emerging markets.
The CRO industry has been witnessing strategic deals between
large global CROs with broad therapeutic and functional expertise,
and subcontracting local CROs. This will enable global CROs to
increase their market access capabilities, thereby further
increasing the extent of their outsourcing activities. The entry of
new participants into the biopharmaceutical sector will augment the
drug discovery and development market in Asian countries. For
example, Samsung Electronics entered into the biopharmaceutical
market in April 2011 through the
formation of Samsung Biologics, a joint venture company between
Samsung Electronics and Quintiles. In December, 2011 Samsung
entered into another agreement with Biogen Idec to set up a joint
venture for the development, manufacture and marketing of
biosimilars.
Scope
- Detailed overview of global trends in pharmaceutical R&D,
followed by market segmentation of the Asian drug discovery and
development market in seven major countries, which are China, India,
Japan, South Korea, Taiwan, Russia and Singapore.- Annualized market data from 2007
and forecasts to 2018.- Strategies adopted by global pharmaceutical
companies in outsourcing R&D processes to Asian countries,
along with the strategic context for deciding locations in
Asia for conducting clinical
research.- Competitive landscape analysis, with profiles of the
leading companies such as Quintiles Transnational Corp,
Pharmaceutical Product Development Inc., Covance Inc., Parexel
International Corporation and Charles River Laboratories
International, Inc.- Analysis of partnership and M&A deals from
2004 to June 2012 along with
segmentation by year and geography, deal type, and phases of
development.
Reasons to buy
- Align your product portfolio to markets with high growth
potential.- Develop market-entry and market expansion strategies by
identifying the key areas for high growth and opportunities.-
Understand the factors shaping the Asian drug discovery and
development market.- Identify the key players best positioned to
take the advantage of the opportunities in the Asian drug discovery
and development market.- Accelerate and strengthen your market
position by identifying key companies for mergers, acquisitions and
strategic partnerships.1 Table of Contents1 Table of Contents 51.1
List of Tables 71.2 List of Figures 92 Drug Discovery and
Development Market in Asia -
Introduction 113 Drug Discovery and Development Market in
Asia - Overview 123.1 Introduction
123.1.1 New Molecule Entity Applications Filed and Approved 123.1.2
Total Industry Spend on R&D and Cost to Develop New Drug 143.2
Industry Trends 153.2.1 Spending on R&D 153.2.2 R&D
Expenditure, Percent Invested on the Development of Biologics 164
Drug Discovery and Development Market in Asia - Market Segmentation 174.1
Industry-Sponsored Phase II/III Trials 194.2 Clinical Trials by
Therapy Area 224.3 Drug Discovery and Development Market Size
244.3.1 China 264.3.2 India 284.3.3 Russia 304.3.4 Japan 324.3.5 South
Korea 344.3.6 Singapore
364.3.7 Taiwan 375 Drug Discovery
and Development Market in Asia -
Strategic Locations 385.1 Population 385.2 Patients Recruited 405.3
Contract Research Organizations (CRO) 415.4 Total Number of Sites
for Clinical Trials 435.5 Gross Domestic Product (Purchasing Power
Parity) 465.6 Total Healthcare Expenditure as a Percentage of GDP
475.7 Cost Comparison 485.7.1 Tax Credits 485.8 Comparison between
Countries 506 Drug Discovery and Development Market in Asia - Strategic Shift in R&D 526.1
Introduction 526.2 Switch from Linear Blockbuster Model to
Innovation Model 536.2.1 Innovation Model 556.3 Strategies for
Designing Drug Discovery and Development Model for Global Market
586.4 R&D Rise in Asia 606.4.1
R&D by Geographic Area, PhRMA Member Companies, 2010 636.5 New
Strategic Outsourcing Models to Meet Changing Clinical Development
Needs 656.5.1 Tactical Outsourcing 656.5.2 referred Provider
Relationship 656.5.3 Functional Service Provider Model 666.5.4
Business Process Outsourcing 666.5.5 Full-Development Outsourcing
666.6 Technology - Central Lab Service Model 677 Drug Discovery and
Development Market in Asia -
Regulatory Landscape 707.1 Introduction 707.2 Taiwan 717.3 South
Korea 737.3.1 IND Application Process 737.3.2 NDA Approval
Process 747.4 Japan 747.4.1 IND
Application Process 747.4.2 NDA Approval Process 767.5 Russia 767.6 Timelines for Obtaining Approval
for Conducting Clinical Trials in Russia 777.7 India 777.7.1 Clinical Trials Registry India
777.7.2 Clinical Trial Regulation in India 797.7.3 Timeframe for Approval 817.8
China 827.8.1 The Ministry of
Health 827.8.2 State Food and Drug Administration 827.8.3 Clinical
Trials Registry China 837.8.4 Clinical Trial Regulation in
China 847.8.5 Structure and
Procedure for Monitoring Adverse Drug Reactions in China 887.9 Singapore 898 Drug Discovery and Development
Market in Asia - Leading Five CROs
918.1 Quintiles 918.2 Pharmaceutical Product Development 938.3
Covance 958.4 PAREXEL International Corporation 968.5 Charles River
Laboratories International 979 Drug Discovery and Development
Market in Asia - Deals Analysis
989.1 By Year 989.2 By Phase 999.3 By Type 10010 Drug Discovery and
Development Market in Asia -
Appendix 10110.1 Market Definitions 10110.2 Abbreviations 10110.3
Bibliography 10210.4 Research Methodology 10410.4.1 Coverage
10410.4.2 Secondary Research 10510.4.3 Primary Research 10510.4.4
Expert Panel Validation 10510.5 Contact Us 10610.6 Disclaimer
106
1.1 List of Tables
Table 1: Drug Discovery and Development Market, the US, Total
Number of NME Applications Filed and Approved, 2002-2011 13Table 2:
Drug Discovery and Development Market, the US, R&D Expenditure
Versus Average Cost to Develop One NME ($bn), 2003-2011 14Table 3:
Drug Discovery and Development Market, Global, R&D Expenditure
Versus Turnover for the Top Seven Pharmaceutical Companies, 2011
15Table 4: Drug Discovery and Development Market, Global,Top Seven
Companies R&D Expenditure on Biologics (%), 2011 16Table 5:
Drug Discovery and Development Market in Asia, Total Number of Studies (Phase I-IV),
2012 by Geography, Through June 2012
17Table 6: Drug Discovery and Development Market in Asia, Total Number of Industry-Sponsored
Clinical Research Studies (Phase I-IV) by Country, Through
June 2012 18Table 7: Drug Discovery
and Development Market in Asia,
Market Segmentation, Phase II and Phase III Industry-Sponsored
Trials by Country, 2005-2012 20Table 8: Drug Discovery and
Development Market in Asia, Phase
II and Phase III Industry-Sponsored Trials by Country, Growth Rate
(%), 2005-2012 21Table 9: Drug Discovery and Development Market in
Asia, Clinical Trials by Therapy
Area by Country, Through June 2012
23Table 10: Drug Discovery and Development Market in Asia, Revenue ($bn), 2007-2011 24Table 11:
Drug Discovery and Development Market in Asia, Revenue Forecasts ($bn), 2011-2018
24Table 12: Drug Discovery and Development Market in Asia, China,
Revenue ($m), 2007-2011 26Table 13: Drug Discovery and Development
Market in Asia, China, Revenue Forecasts ($m), 2011-2018
26Table 14: Drug Discovery and Development Market in Asia, India,
Revenue ($m), 2007-2011 28Table 15: Drug Discovery and Development
Market in Asia, India, Revenue Forecasts ($m), 2011-2018
28Table 16: Drug Discovery and Development Market in Asia, Russia,
Revenue ($m), 2007-2011 30Table 17: Drug Discovery and Development
Market in Asia, Russia, Revenue Forecasts ($m), 2011-2018
30Table 18: Drug Discovery and Development Market in Asia, Japan,
Revenue ($m), 2007-2011 32Table 19: Drug Discovery and Development
Market in Asia, Japan, Revenue Forecasts ($m), 2011-2018
32Table 20: Drug Discovery and Development Market in Asia, South
Korea, Revenue ($m), 2007-2011 34Table 21: Drug Discovery
and Development Market in Asia,
South Korea, Revenue Forecasts
($m), 2011-2018 34Table 22: Drug Discovery and Development Market
in Asia, Singapore, Revenue ($m), 2007-2011 36Table 23:
Drug Discovery and Development Market in Asia, Singapore, Revenue Forecasts ($m), 2011-2018
36Table 24: Drug Discovery and Development Market in Asia, Taiwan,
Revenue ($m), 2007-2011 37Table 25: Drug Discovery and Development
Market in Asia, Taiwan, Revenue Forecasts ($m), 2011-2018
37Table 26: Drug Discovery and Development Market in Asia, Population (Millions) by Country,
2007-2011 39Table 27: Drug Discovery and Development Market in
Asia, Patient Recruitment and
Growth Rates by Country (%) 40Table 28: Drug Discovery and
Development Market in Asia, Number
of CROs by Country, 2012 41Table 29: Drug Discovery and Development
Market in Asia, Total Number of
Clinical Trial Investigator Sites by Country, 2006-2008 43Table 30:
Drug Discovery and Development Market in Asia, Total Number of Clinical Trial
Investigator Sites by Major Cities, 2006-2008 44Table 31: Drug
Discovery and Development Market in Asia, GDP ($bn) by Country, January 2011 46Table 32: Drug Discovery and
Development Market in Asia, Total
Healthcare Expenditure % GDP by Country, 2007-2010 47Table 33: Drug
Discovery and Development Market in Asia, Cost Efficiency for Conducting Clinical
Trials by Country, 2012 48Table 34: Drug Discovery and Development
Market in Asia, Scale for Overall
Country Attractiveness by Country, 2012 50Table 35: Drug Discovery
and Development Market, Global, R&D Expenditure ($m) by PhRMA
Member Companies by Stage, 2010 57Table 36: Drug Discovery and
Development Market in Asia, Core
R&D Facilities of Top Ten Pharmaceutical Companies, 2010
60Table 37: Drug Discovery and Development Market, Global, R&D
Expenditures ($m) by PhRMA Member Companies, 2010 64Table 38: Drug
Discovery and Development Market in Asia, Russia,
Timeline for Clinical Trial Approval (Days), 2005-2009 77Table 39:
Drug Discovery and Development Market in Asia, India,
Timeframe for Approval of New Drugs, 2009 81Table 40: Drug
Discovery and Development Market in Asia, China,
Number of Days Required for Obtaining Approval for Clinical Trials,
2010 85Table 41: Drug Discovery and Development Market in
Asia, China, Number of Days Required for Obtaining
Approval for Clinical Trials for Imported Drugs, 2010 87Table 42:
Drug Discovery and Development Market in Asia, Deals by Year and Geography, 2004-2012
98Table 43: Drug Discovery and Development Market in Asia, Deals by Phase, 2004-2012 99Table 44:
Drug Discovery and Development Market in Asia, Deals by Type, 2004-2012 100
1.2 List of Figures
Figure 1: Drug Discovery and Development Market, The US, Total
Number of NME Applications Filed and Approved, 2002-2011 12Figure
2: Drug Discovery and Development Market, the US, R&D
Expenditure Versus Average Cost to Develop One NME ($bn), 2003-2011
14Figure 3: Drug Discovery and Development Market, Global, R&D
Expenditure Versus Turnover for the Top Seven Pharmaceutical
Companies, 2011 15Figure 4: Drug Discovery and Development Market
in Asia, Total Number of Clinical
Research Studies (Phase I-IV), (%) by Geography, Through
June 2012 17Figure 5: Drug Discovery
and Development Market in Asia,
Phase II and Phase III Industry-Sponsored Trials by Country,
2005-2012 19Figure 6: Drug Discovery and Development Market in
Asia, Phase II and Phase III
Industry-Sponsored Trials by Country, Growth Rate (%), 2005-2012
21Figure 7: Drug Discovery and Development Market in Asia, Clinical Trials by Therapy Area by
Country, Through June 2012 22Figure
8: Drug Discovery and Development Market in Asia, Revenue Forecasts ($bn), 2007-2018
24Figure 9: Drug Discovery and Development Market in Asia, China,
Revenue Forecasts ($m), 2007-2018 26Figure 10: Drug Discovery and
Development Market in Asia,
India, Revenue Forecasts ($m),
2007-2018 28Figure 11: Drug Discovery and Development Market in
Asia, Russia, Revenue Forecasts ($m), 2007-2018
30Figure 12: Drug Discovery and Development Market in Asia, Japan,
Revenue Forecasts ($m), 2007-2018 32Figure 13: Drug Discovery and
Development Market in Asia,
South Korea, Revenue Forecasts
($m), 2007-2018 34Figure 14: Drug Discovery and Development Market
in Asia, Singapore, Revenue Forecasts ($m), 2007-2018
36Figure 15: Drug Discovery and Development Market in Asia, Taiwan,
Revenue Forecasts ($m), 2007-2018 37Figure 16: Drug Discovery and
Development Market in Asia,
Population (Millions) by Country, 2007-2011 38Figure 17: Drug
Discovery and Development Market in Asia, Number of CROs by Country, 2012 41Figure
18: Drug Discovery and Development Market in Asia, Total Number of Clinical Trial
Investigator Sites by Country, 2006-2008 43Figure 19: Drug
Discovery and Development Market in Asia, GDP ($bn) by Country, January 2011 46Figure 20: Drug Discovery and
Development Market in Asia, Total
Healthcare Expenditure % GDP by Country, 2007-2010 47Figure 21:
Drug Discovery and Development Market in Asia, Scale for Overall Country Attractiveness
by Country, 2012 50Figure 22: Drug Discovery and Development
Market, Factors Causing Changes in the Business Model of
Pharmaceutical Companies in Mature Markets, 2012 52Figure 23: Drug
Discovery and Development Market, Global, Switch from Linear
Blockbuster Model to Innovation Model, 2012 53Figure 24: Drug
Discovery and Development Market, Global, Switch from Linear
Blockbuster Model to Innovation Model, 2012 54Figure 25: Drug
Discovery and Development Market, Global, Innovation Model
Involving Multiple Alliances and Partnerships, 2012 55Figure 26:
Drug Discovery and Development Market, Global, R&D Expenditure
(%) by PhRMA Member Companies by Stage, 2010 57Figure 27: Drug
Discovery and Development Market, Stepwise Approach for Designing
Drug Discovery and Development Strategies, 2012 58Figure 28: Drug
Discovery and Development Market, Global, Therapeutic and Market
Analysis Steps in Designing Drug Discovery and Development
Strategies, 2012 59Figure 29: Drug Discovery and Development Market
in Asia, Asia Oncology Strategic
Alliance, Case Study, 2007 62Figure 30: Drug Discovery and
Development Market, Global, R&D Expenditures (%) by PhRMA
Member Companies, 2010 63Figure 31: Drug Discovery and Development
Market in Asia. New Strategic
Clinical Outsourcing Models, 2010 65Figure 32: Drug Discovery and
Development Market in Asia,
R&D by Function, PhRMA Member Companies, 2010 67Figure 33: Drug
Discovery and Development Market in Asia, Data Integration Linking Clinical Trial
Patient Data to Central Laboratory Data via Oracle-Based Exchange
Platform, 2011 68Figure 34: Drug Discovery and Development Market
in Asia, Oracle-Based Exchange
Platform, 2011 69Figure 35: Drug Discovery and Development Market
in Asia, Regulatory Approval
Process and Timeline for Clinical Research, 2012 70Figure 36: Drug
Discovery and Development Market in Asia, , Taiwan, NDA Review Process, 2011 71Figure 37:
Drug Discovery and Development Market in Asia, Taiwan,
Timeline for Consultation with CDE for Medicinal Products, 2011
72Figure 38: Drug Discovery and Development Market in Asia, South
Korea, IND and NDA Review and Approval Process, 2012
73Figure 39: Drug Discovery and Development Market in Asia, South
Korea, Drug Approval Process, 2012 74Figure 40: Drug
Discovery and Development Market in Asia, Japan,
Flowchart of New Drug Development and Approval Process, 2011
75Figure 41: Drug Discovery and Development Market in Asia, Japan,
Timeline for Approval, 2011 76Figure 42: Drug Discovery and
Development Market in Asia,
India, Procedure for Registering
Clinical Trials with the CTRI, 2009 78Figure 43: Drug Discovery and
Development Market in Asia,
India, Clinical Trial Regulation
Approval Process, 2009 79Figure 44: Drug Discovery and Development
Market in Asia, China, Procedure for Registering Clinical
Trials with ChiCTR, 2010 83Figure 45: Drug Discovery and
Development Market in Asia ,
China, Clinical Trial Regulation
Approval Process, 2010 84Figure 46: Drug Discovery and Development
Market in Asia, China, Clinical Trial Regulation Approval
Process for Imported Drugs, 2010 86Figure 47: Drug Discovery and
Development Market in Asia,
China, Structure for Reporting and
Monitoring ADRs, 2010 88Figure 48: Drug Discovery and Development
Market in Asia, Singapore, Registration Process for a
Medicinal Product, 2009 89Figure 49: Drug Discovery and Development
Market in Asia, Singapore, Target Processing Timelines, 2012
90Figure 50: Drug Discovery and Development Market in Asia, Company Profiles, Quintiles, 2012
91Figure 51: Drug Discovery and Development Market in Asia, SWOT Analysis, Quintiles, 2012 92Figure
52: Drug Discovery and Development Market in Asia, Company Profiles, Pharmaceutical Product
Development (PPD), 2012 93Figure 53: Drug Discovery and Development
Market in Asia, SWOT Analysis,
Pharmaceutical Product Development (PPD), 2012 94Figure 54: Drug
Discovery and Development Market in Asia, Company Profiles, Covance, 2012 95Figure
55: Drug Discovery and Development Market in Asia, SWOT Analysis, Covance, 2012 95Figure
56: Drug Discovery and Development Market in Asia, Company Profiles, Parexel, 2012 96Figure
57: Drug Discovery and Development Market in Asia, SWOT Analysis, Parexel, 2012 96Figure
58: Drug Discovery and Development Market in Asia, Company Profiles, Charles River
Laboratories International, 2012 97Figure 59: Drug Discovery and
Development Market in Asia, SWOT
Analysis, Charles River Laboratories International, 2012 97Figure
60: Drug Discovery and Development Market in Asia, Deals by Year and Geography, 2004-2012
98Figure 61: Drug Discovery and Development Market in Asia, Deals by Phase, 2004-2012 99Figure 62:
Drug Discovery and Development Market in Asia, Deals by Type, 2004-2012 100
To order this report:Drug_Discovery_and_Development
Industry: Drug Discovery and Development Market in Asia -
Partnerships Between MNCs and Asian Academic Institutions and
Healthcare Research Organizations are Driving R&D Innovation
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker